MS
Therapeutic Areas
Spedding Research Solutions Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ALS/Neurodegenerative Program | Amyotrophic Lateral Sclerosis (ALS), Parkinson's Disease | Phase 2 |
| COVID-19/SARS-CoV-2 Program | COVID-19 | Pre-clinical |
| Drug | Indication | Phase |
|---|---|---|
| ALS/Neurodegenerative Program | Amyotrophic Lateral Sclerosis (ALS), Parkinson's Disease | Phase 2 |
| COVID-19/SARS-CoV-2 Program | COVID-19 | Pre-clinical |